Daisy Chavez, | |
12141 Brookhurst St Ste 201, Garden Grove, CA 92840-2865 | |
(657) 261-7140 | |
(714) 922-1032 |
Full Name | Daisy Chavez |
---|---|
Gender | Female |
Speciality | Community Health Worker |
Location | 12141 Brookhurst St Ste 201, Garden Grove, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376213736 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (California) | Secondary |
172V00000X | Community Health Worker | (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Daisy Chavez, 12141 Brookhurst St Ste 201, Garden Grove, CA 92840-2865 Ph: (657) 261-7140 | Daisy Chavez, 12141 Brookhurst St Ste 201, Garden Grove, CA 92840-2865 Ph: (657) 261-7140 |
News Archive
Chief Health Officer Charles Guest's report on the health and wellbeing of the Australian Capital Territory (ACT) population between July 2006 and June 2008 was presented in the Legislative Assembly. It showed that life expectancy rate at birth in the ACT was 80.3 years for males and 84 for women. This was despite the fact that most are overweight and only a minority eats enough fruit and vegetables.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.
A federal appeals court backed the Obama administration's drive to levy greater punishments on pharmaceutical executives tied to corporate wrongdoing, saying the administration could effectively derail the executives' careers by barring them from doing business with federal programs including Medicare.
​Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have developed a method to synthesize modified forms of an established antibiotic called spectinomycin.
› Verified 1 days ago